Life Sciences
Asia-Pacific Guide 2024 : Asia-Pacific Region
Band 2
Contact number
+852 3405 2300Chambers Review
Norton Rose Fulbright handles complex M&A mandates for global companies investing in Asia, particularly in the pharmaceuticals field, and offers a well-established IP practice especially on the patent protection front, as well as regulatory compliance matters throughout its Asia network. It also advises on issues relating to clinical trial agreements, compliance investigations research, licensing, research and collaboration arrangements. The firm is particularly well placed to handle Australian or Chinese mandates – or deals spanning those jurisdictions.
Justin Davidson in Hong Kong and Bernard O'Shea in Melbourne are both key contacts.
Work Highlights
- Norton Rose Fulbright advised Sonic, a global provider of medical diagnostics with specialist operations in laboratory medicine, pathology and radiology services, on the formation of a joint venture company with Harrison-AI.
- Norton Rose Fulbright advised Tillotts Pharma in relation to a patent for ASACOL/lactose-free formulation and a patent for a delayed release drug formulation.
Strengths
Provided by Chambers
"The team at NRF are responsive and provide advice in a timely manner, and at a level of detail that is fit for purpose."
"I have always found the team to be very responsive and that their service levels are high."
"The team at NRF are responsive and provide advice in a timely manner, and at a level of detail that is fit for purpose."
"I have always found the team to be very responsive and that their service levels are high."